EE29 Cost-Effectiveness of Niraparib Plus Abiraterone Acetate and Prednisone for Metastatic Castration-Resistant Prostate Cancer
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.330
https://www.valueinhealthjournal.com/article/S1098-3015(24)00445-5/fulltext
Title :
EE29 Cost-Effectiveness of Niraparib Plus Abiraterone Acetate and Prednisone for Metastatic Castration-Resistant Prostate Cancer
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00445-5&doi=10.1016/j.jval.2024.03.330
First page :
Section Title :
Open access? :
No
Section Order :
11679